| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.78B | 53.75B | 52.78B | 47.95B | 41.30B | 35.56B |
| Gross Profit | 12.01B | 11.99B | 14.08B | 11.41B | 9.28B | 14.58B |
| EBITDA | 8.38B | 8.06B | 9.40B | 5.43B | 7.06B | 5.48B |
| Net Income | 4.65B | 5.17B | 6.24B | 3.32B | 4.64B | 3.21B |
Balance Sheet | ||||||
| Total Assets | 49.30B | 44.62B | 39.26B | 31.87B | 33.83B | 29.94B |
| Cash, Cash Equivalents and Short-Term Investments | 21.86B | 19.02B | 14.58B | 10.49B | 11.63B | 10.97B |
| Total Debt | 2.44B | 1.51B | 931.77M | 1.02B | 1.23B | 1.28B |
| Total Liabilities | 11.30B | 9.84B | 8.82B | 7.39B | 8.00B | 8.15B |
| Stockholders Equity | 38.00B | 34.78B | 30.44B | 24.48B | 25.83B | 21.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.73B | 6.92B | 5.03B | 2.17B | 5.33B |
| Operating Cash Flow | 5.56B | 6.22B | 7.18B | 5.61B | 2.81B | 5.58B |
| Investing Cash Flow | -2.54B | -4.84B | -6.27B | 2.52B | -3.07B | -4.44B |
| Financing Cash Flow | -2.16B | -2.03B | -1.55B | -6.36B | -1.47B | -968.69M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ₹69.07B | 23.90 | ― | 2.00% | 12.39% | 59.77% | |
70 Outperform | ₹49.18B | 14.66 | ― | 1.62% | 11.91% | -1.02% | |
69 Neutral | ₹140.97B | 28.61 | ― | 0.02% | 17.83% | 20.34% | |
68 Neutral | ₹57.76B | 42.91 | ― | 1.26% | 21.31% | -16.27% | |
62 Neutral | ₹102.41B | 25.31 | ― | 1.42% | -2.00% | -25.81% | |
62 Neutral | ₹126.68B | 19.99 | ― | 1.75% | 9.16% | 7.77% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |